# Research from Soni
## Overview
==In this step i screened systematically the top 1720 correlations (DisGeNet and Go enrich input) if they are part of the top gene dataset.==

We hypothesize that ADAR1-mediated RNA editing via MDA5-PKR IFN-β activation plays a critical role in abnormal SMC proliferation and autoimmune inflammation during vascular remodeling.
*(Kim, Y., et al. "PKR Activation Caused by ADAR1 Deficeincy Contributes to Vascular Remodeling in PAH." D95. SURVEYING THE ZOO:-OMICS FOR MECHANISTIC DISCOVERY IN PULMONARY VASCULAR DISEASE. American Thoracic Society, 2024. A7244-A7244.)*

We hypothesized that NLRP3 inflammasome activation mediates RVCM contractile dysfunction and that this is attenuated by E2 via estrogen receptor (ER) α.
*(Sobrano Fais, R., et al. "NLRP3-induced Contractile Dysfunction in Right Ventricle Cardiomyocytes Is Sexually Dimorphic and Modified by 17β-estradiol Via Estrogen Receptor α." B95. SURFING IN THE GREEN ROOM: DEFINING MOLECULAR MECHANISMS OF PULMONARY VASCULAR DISEASE. American Thoracic Society, 2024. A4695-A4695.)*

Single-cell RNA sequencing on sorted lineage-labeled GLI1+ cells revealed an _Acta2__high_ fraction of cells with pathways in cancer and MAPK (mitogen-activated protein kinase) signaling as potential players in reprogramming these cells during vascular remodeling. Our data highlight GLI1+ cells as an alternative cellular source of VSMCs (Vascular smooth muscle cell) in pulmonary hypertension and suggest that these cells and the associated signaling pathways represent an important therapeutic target for further studies.
*(Chu, Xuran, et al. "GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension." Circulation Research 134.11 (2024): e133-e149.)*

Genetic diagnostics and molecular approaches in pulmonary arterial hypertension
![[Pasted image 20240925142515.png]]
(BMPR2, ATP13A3, AQP1, ABCC8, KCNK3, SMAD9, SOX17, CAV1, TBX4, EIF2AK4, KDR, ENG, ACVRL1, GDF2)
*(Eichstaedt, Christina A., et al. "Genetische Diagnostik und molekulare Ansätze bei pulmonalarterieller Hypertonie." Pneumologie 77.11 (2023): 862-870.)*

The circulating levels of several extracellular matrix proteins deregulated in decompensated RV subgroups were assessed in two independent cohorts of individuals with pulmonary arterial hypertension, revealing that NID1, C1QTNF1 and CRTAC1 predicted the development of a maladaptive RV state, as defined by magnetic resonance imaging parameters, and were associated with worse clinical outcomes.
*(Khassafi, Fatemeh, et al. "Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension." Nature cardiovascular research 2.10 (2023): 917-936.)*

## ==Keywords==
==Ive checked for the following genes if they were found in the set of 1720 target genes (DisGeNet input)==
```
# REspective ENSEMBL IDs OR of IDs of related genes

ADAR1, ENSG00000160710
MDA5-PKR IFN-β, ENSG00000115267
SMC, ENSG00000231822/ENSG00000268364/ENSG00000270332
NLRP3, ENSG00000162711
estrogen,
GLI1+, ENSG00000111087
Acta2, ENSG00000107796
MAPK, ENSG00000250062/ ENSG00000259438/ ENSG00000261399/ ENSG00000157833/ ENSG00000282110/ ENSG00000225663/ ENSG00000141441/ ENSG00000168175/ 
VSMCs,
NID1, ENSG00000116962
C1QTNF1, ENSG00000173918
CRTAC1, ENSG00000095713
PKA, ENSG00000095713
NOCT, ENSG00000151014
IL6, ENSG00000136244
IFNa2 and IFNAR2, ENSG00000188379 and ENSG00000159110
MTC1, ENSG00000232119,

# From the treatment guidelines
BMPR2, ENSG00000204217
ATP13A3, ENSG00000133657
AQP1, ENSG00000240583
ABCC8, ENSG00000006071
KCNK3, ENSG00000171303
SMAD9, ENSG00000120693
SOX17, ENSG00000164736
CAV1, ENSG00000105974
TBX4, ENSG00000121075
EIF2AK4, ENSG00000128829
KDR, ENSG00000128052
ENG, ENSG00000106991
ACVRL1, ENSG00000139567
GDF2, ENSG00000263761

```
